白霉素辅助治疗小儿支原体肺炎的疗效分析

White adriamycin adjuvant treatment of Mycoplasma Pneumonia Rodin

目的：探讨白霉素辅助治疗小儿支气管肺炎的临床疗效。方法：将我院2009年7月-2010年9月收治的58例支气管肺炎患者随机分为观察组30例、对照组28例。观察组采用白霉素、阿奇霉素治疗，对照组仅单用阿奇霉素治疗。比较两组临床治疗效果及药物副作用情况。结果：观察纽30例中痊愈者21例，显效者8例，进步及无效者共1例，患儿治疗总有效率为96．67％（29／30）；对照组28例中痊愈者14例，显效者7例，进步及无效者7例，患儿总有效率为75．00％。两组总有效率比较，观察组明显高于对照组（x^2=4．04，P〈0．05）。两组药物副作用比较，无显著性差异（P〉0．05）。结论：白霉素辅助阿奇霉素治疗小儿支原体肺炎，临床疗效较好，可于临床推广应用。

Objective To investigate the adjuvant treatment of white-ADM clinical efficacy of bronchial pneumonia in children. Method to our hospital in July 2009 - September 2010 58 patients with bronchial pneumonia treated patients were randomly divided into two groups of 30 cases, 28 patients in control group. Observation group were white adriamycin, azithromyein, alone in the control group only azithromycin. Two groups were compared clinical efficacy and side effects situation. Results observed in 30 cases recovered, 21 cases, effective in 8 cases, progress and were ineffective in 1 case, children with total effective rate was 96.67% （29/30）; control group, 28 patients recovered in 14 cases, effective 7 cases, progress, and ineffective in 7 cases, total effective rate was 75.00% in children. The total effective rate compared to the observation group was significantly higher （x2 = 4.04, P 〈0.05）. Comparing the two groups of drug side effects, no significant difference （P〉 0.05）. Conclusion Azithromycin treatment of secondary white adriamycin mycoplasma pneumonia, better clinical efficacy, in clinical application.